?
Bassler Bonnie L
Director
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK
1683607
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
1,548
Price per Share :
$703.43
Equivalence :
$1,088,909.64
Transaction History
-
A1,548 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/02/25
-
Footnotes
-
-
Footnotes:#1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
-
M2,209 Shares After TransactionValue : $841,518.55$315,045.65Transaction Date : 01/30/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 11, 2023.
-
S1,382 Shares After TransactionValue : $1,325,338.00Sold $793,093.00Transaction Date : 01/30/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 11, 2023.
-
M2,138 Shares After TransactionValue : $794,053.20$280,778.40Transaction Date : 08/02/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 27, 2024.
-
S1,382 Shares After TransactionValue : $1,540,930.00Sold $842,940.00Transaction Date : 08/02/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 27, 2024.